Advertisement
Advertisement

BOLT

BOLT logo

Bolt Biotherapeutics, Inc. Common Stock

3.99
USD
Sponsored
-0.06
-1.48%
Aug 10, 16:00 UTC -4
Closed
exchange

After-Market

4.05

+0.06
+1.58%

Bolt Biotherapeutics, Inc. Common Stock Profile

About

Bolt Biotherapeutics Inc. is a clinical-stage immuno-oncology company. It engages in the discovery, development, and commercialization of pharmaceutical products. The company's principal product includes BDC-1001. Bolt Biotherapeutics Inc. is based in Redwood city, California.

Info & Links

CEO

William P. Quinn

Headquarters

900 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.boltbio.com

Auditor

PricewaterhouseCoopers LLP

Share holders

11

Employees

23

Bolt Biotherapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

7.79M

Enterprise Value

15.33M

Enterprise Value/EBITDA(ttm)

-0.49

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.20

Price to Book(mrq)

0.39

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-455.15%

Profit Margin(ttm)

-7232.68%

Return on Equity(ttm)

-100.89%

Return on Invested Capital(ttm)

-60.35%

Return on Assets(ttm)

-48.23%

Income Statement

Revenue(ttm)

6.50M

Revenue Per Share(ttm)

3.38

Gross Profit(ttm)

6.50M

EBITDA(ttm)3

-31.01M

Net Income Available to Common(ttm)

-29.58M

Diluted EPS(ttm)

-16.33

Share Statistics

Beta (5Y Monthly)

1.18

52-Week Change

-28.37%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

1.92M

Dividend Yield

0.00%

Float4

1.74M

% Held by Insiders

9.40%

% Held by Institutions

86.70%

Balance Sheet

Total Cash(mrq)

23.09M

Total Cash Per Share(mrq)

12.02

Total Debt(mrq)

19.35M

Total Debt/Equity(mrq)

97.63%

Current Ratio(mrq)

3.51%

Quick Ratio(mrq)

3.51%

Book Value Per Share(mrq)

10.31

Cash Flow

Operating Cash Flow Per Share(ytd)

-4.78

Free Cash Flow(ytd)

-7.99M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement